Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001193125-26-037697

President, CEO and CFO bought 125 shares at $4.61 ($576)

From the SEC's structured data for this filing

Trades in this filing

Quinn William P. · President, CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-05 Purchase : show line 1 in the form +125 $4.61 $576 2,313 D
Open-market purchases · 125 sh · avg $4.61 · $576

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-28 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +20,000 20,000 D
Loading xslF345X05/ownership.xml…